Latest Clinical & Research News
A growing set of low-risk cancers, including early-stage thyroid and kidney cancers, is associated with excellent outcomes regardless of management strategy. Given the risks associated with overtreatment of these cancers, it follows that many patients should be treated nonoperatively. Read More
Nathan P. Thomas, MD, PhD, Antonia F. Chen, MD, MBA, in the Department of Orthopaedic Surgery at Brigham and Women’s Hospital, and colleagues compared manipulation under anesthesia or arthroscopic lysis of adhesions in the largest cohort in current literature.
Read More...
Researchers at Brigham and Women’s Hospital recently demonstrated that the post-surgical global period is a critical timepoint influencing follow-up rates. At six months, follow-up was lowest for patients on Medicaid.
Read More...
Brigham rheumatologist and Lupus Program director Karen Costenbader, MD, MPH, helped develop a risk prediction model for systemic lupus erythematosus (SLE) incorporating genetic, environmental, and lifestyle risk factors, as well as family history. Clinicians one day may use the model to predict individuals’ SLE risks.
Read More...
The Society of Surgical Oncology (SSO) is holding its annual International Conference on Surgical Cancer Care in Boston on March 22-25.
Several leaders in surgical oncology from Brigham and Women’s Hospital/Dana-Farber Brigham Cancer Center will present their latest research and clinical advancements in breast cancer, colorectal cancer, melanoma, sarcoma, and more. Read More
Researchers at Brigham and Women’s Hospital have developed a stretchable double-network hydrogel bioink system for microfluidic bioprinting of small-diameter vascular conduits. They say the conduits recapitulate the structural and biological functions of native blood vessels.
Read More...
Researchers at Brigham and Women’s Hospital recently demonstrated that lesions causing depression in patients with stroke or penetrating head trauma were functionally connected to a common brain circuit.
Read More...
Key decision points in multiple sclerosis (MS) management would benefit from precision medicine—using information about an individual’s genomics, environment, and lifestyle, not just their signs and symptoms—to subtype their disease and make personalized decisions about their treatment.
Read More...
In the first large, population-based cohort study of the issue, researchers at Brigham and Women’s Hospital found 22% of eligible patients declined statin therapy initially and 6% never accepted the recommendation. Results on both measures were significantly higher for women than men.
Read More...
Building on previous findings, Brigham and Women’s Hospital researchers report that the immunity imbalance predisposing to herpes simplex virus-2 (HSV-2) isn’t limited to the cervix but rather extends to the systemic circulation. HSV-2 may alter both mucosal and peripheral innate immunity to contribute to HIV-1 risk.
Read More...